Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Graft-versus-Host Disease

Extracorporeal photochemotherapy may improve outcome in children with acute GVHD

Abstract

Acute GVHD (aGVHD) is a major cause of morbidity and mortality after unrelated BMT (UBMT). Our purpose was to analyze the role of extracorporeal photochemotherapy (ECP) in controlling grade II–IV aGVHD in children given UBMT. Of 41 consecutive children, 31 developed grade II–IV aGVHD after UBMT: 16 had a good response to steroids (GR group), whereas 15 underwent ECP (ECP group) within 100 days of UBMT. Eligibility criteria for starting ECP were steroid resistance, dependence or viral reactivations. Criteria for judging response to aGVHD treatment were that the resolution of all signs were considered a complete response (CR), at least a 50% improvement was classified as a partial response (PR) and stable or progressive disease was judged as no response (NR). On completing ECP, the CR rate was 73%, whereas the GR group had a CR rate of 56% by day 100. The 2-year overall survival and progression-free survival rates were 57 and 67% in the GR group vs 85 and 87% in the ECP group. Our data seem to suggest that ECP may improve outcome in patients after UBMT. These findings need to be confirmed in a larger population.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Nash RA, Antin JH, Karanes C, Fay JW, Avalos BR, Yeager AM et al. Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors. Blood 2000; 96: 2062–2068.

    CAS  PubMed  Google Scholar 

  2. Bacigalupo A . Management of acute graft-versus-host disease. Br J Haematol 2007; 137: 87–98.

    Article  CAS  PubMed  Google Scholar 

  3. Deeg HJ, Loughran Jr TP, Storb R, Kennedy MS, Sullivan KM, Doney K et al. Treatment of human acute graft-versus-host disease with antithymocyte globulin and cyclosporine with or without methylprednisolone. Transplantation 1985; 40: 162–166.

    Article  CAS  PubMed  Google Scholar 

  4. Pavletic S, Tarantolo S, Lynch J, Oria N, Ketcham M, Brand R et al. Acute graft-versus-host disease after allogeneic blood stem cell transplantation: factors determining treatment failure and survival. Blood 1999; 94 (Suppl 1): 153a.

    Google Scholar 

  5. Messina C, Locatelli F, Lanino E, Uderzo C, Zacchello G, Cesaro S et al. Extracorporeal photochemotherapy for paediatric patients with graft-versus-host disease after haematopoietic stem cell transplantation. Br J Haematol 2003; 122: 118–127.

    Article  CAS  PubMed  Google Scholar 

  6. Peritt D . Potential mechanisms of photopheresis in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2006; 12: 7–12.

    Article  CAS  PubMed  Google Scholar 

  7. Ferrara JL, Deeg HJ . Graft-versus-host disease. N Engl J Med 1991; 324: 667–674.

    Article  CAS  PubMed  Google Scholar 

  8. Sullivan KM, Agura E, Anasetti C, Appelbaum F, Badger C, Bearman S et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 1991; 28: 250–259.

    CAS  PubMed  Google Scholar 

  9. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825–828.

    CAS  PubMed  Google Scholar 

  10. Deeg HJ, Storb R . Graft-versus-host disease: pathophysiological and clinical aspects. Annu Rev Med 1984; 35: 11–24.

    Article  CAS  PubMed  Google Scholar 

  11. Greinix HT, Knobler RM, Worel N, Schneider B, Schneeberger A, Hoecker P et al. The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease. Haematologica 2006; 91: 405–408.

    PubMed  Google Scholar 

  12. Couriel DR, Hosing C, Saliba R, Shpall EJ, Anderlini P, Rhodes B et al. Extracorporeal photochemotherapy for treatment of steroid-resistant chronic GVHD. Blood 2006; 107: 3074–3080.

    Article  CAS  PubMed  Google Scholar 

  13. Marubini E, Valsecchi MG . Analysing Survival Data from Clinical Trials and Observational Studies. Wiley: Chichester, 1995.

    Google Scholar 

Download references

Acknowledgements

We gratefully acknowledge MC Putti for critically reviewing the article. We also thank I Taddeo, A Eccellente and S Gallo for their excellent secretarial assistance. CM is particularly grateful to Professor L Zanesco for his guidance and sage advice over the years. This work was supported by the Fondazione Città della Speranza and AIL (Associazione Italiana Leucemie e Linfomi).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C Messina.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Calore, E., Calò, A., Tridello, G. et al. Extracorporeal photochemotherapy may improve outcome in children with acute GVHD. Bone Marrow Transplant 42, 421–425 (2008). https://doi.org/10.1038/bmt.2008.174

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2008.174

Keywords

This article is cited by

Search

Quick links